Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Inventory (2018 - 2025)

TELA Bio has reported Change in Inventory over the past 8 years, most recently at $275000.0 for Q4 2025.

  • Quarterly results put Change in Inventory at $275000.0 for Q4 2025, down 55.36% from a year ago — trailing twelve months through Dec 2025 was $503000.0 (down 83.08% YoY), and the annual figure for FY2025 was $503000.0, down 83.08%.
  • Change in Inventory for Q4 2025 was $275000.0 at TELA Bio, down from $838000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for TELA hit a ceiling of $3.9 million in Q1 2023 and a floor of -$2.0 million in Q2 2025.
  • Median Change in Inventory over the past 5 years was $713500.0 (2024), compared with a mean of $873000.0.
  • Biggest five-year swings in Change in Inventory: soared 3493.18% in 2021 and later tumbled 1800.87% in 2025.
  • TELA Bio's Change in Inventory stood at $1.5 million in 2021, then crashed by 131.28% to -$467000.0 in 2022, then tumbled by 68.09% to -$785000.0 in 2023, then soared by 178.47% to $616000.0 in 2024, then tumbled by 55.36% to $275000.0 in 2025.
  • The last three reported values for Change in Inventory were $275000.0 (Q4 2025), $838000.0 (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.